Jasbir Seehra

Insider Reports History

Location
Waltham, MA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jasbir Seehra:

Company Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 385,708 $6,236,898 $16.17 19 Feb 2026 Direct
Keros Therapeutics, Inc. CHIEF EXECUTIVE OFFICER, Director Employee Stock Option (right to buy) 62,500 07 Jan 2026 Direct
Eloxx Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 20,000 15 Jun 2022 Direct

Insider Reports Filed by Jasbir Seehra

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KROS Keros Therapeutics, Inc. 19 Feb 2026 1 -$113,433 4 CHIEF EXECUTIVE OFFICER, Director 20 Feb 2026, 16:15
KROS Keros Therapeutics, Inc. 07 Jan 2026 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 09 Jan 2026, 16:15
KROS Keros Therapeutics, Inc. 03 Sep 2025 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 05 Sep 2025, 16:10
KROS Keros Therapeutics, Inc. 04 Apr 2025 2 +$14,810 4 CHIEF EXECUTIVE OFFICER, Director 07 Apr 2025, 16:15
KROS Keros Therapeutics, Inc. 23 Feb 2024 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 23 Feb 2024, 17:07
KROS Keros Therapeutics, Inc. 13 Feb 2024 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 15 Feb 2024, 20:41
KROS Keros Therapeutics, Inc. 08 Apr 2023 2 +$1,920 4 Chief Executive Officer, Director 11 Apr 2023, 16:05
KROS Keros Therapeutics, Inc. 16 Feb 2023 1 $0 4 Chief Executive Officer, Director 17 Feb 2023, 15:13
/report/000110465922072188-seehra-jasbir-2022-06-15 Eloxx Pharmaceuticals, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 08:28
KROS Keros Therapeutics, Inc. 09 Jun 2022 2 +$1,500 4 Chief Executive Officer, Director 10 Jun 2022, 16:12
KROS Keros Therapeutics, Inc. 21 Jan 2022 1 $0 4 Chief Executive Officer, Director 25 Jan 2022, 15:17
/report/000141588921002610-seehra-jasbir-2021-05-19 Eloxx Pharmaceuticals, Inc. 19 May 2021 1 $0 4 Director 20 May 2021, 16:10